Clarithromycin or levofloxacin in the sequential therapy for H-pylori eradication?

被引：7
|
作者：
Zullo, A. [1 ]
Hassan, C. [1 ]
D'Ercole, C. [1 ]
De Francesco, V. [2 ]
Vaira, D. [3 ]
机构：
[1] Nuovo Regina Margherita Hosp, Dept Gastroenterol & Digest Endoscopy, I-00153 Rome, Italy
[2] Riuniti Hosp, Gastroenterol Unit, Foggia, Italy
[3] Univ Bologna, Dept Internal Med & Gastroenterol, Bologna, Italy
来源：
ALIMENTARY PHARMACOLOGY & THERAPEUTICS | 2010年 / 31卷 / 11期
关键词：
RESISTANCE;
D O I：
10.1111/j.1365-2036.2010.04286.x
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：1248 / 1249
页数：2
相关论文
共 50 条
  • [21] What constitutes failure of H-pylori eradication therapy?
    Malfertheiner, P
    Peitz, U
    Treiber, G
    HELICOBACTER PYLORI: BASIC MECHANISMS TO CLINICAL CURE 2002, 2003, : 391 - 400
  • [22] Roxithromycine in triple therapy for H-pylori eradication.
    Dammann, HG
    Bilke, R
    Burkhardt, F
    Wolf, N
    Walter, TA
    GASTROENTEROLOGY, 1996, 110 (04) : A90 - A90
  • [23] LEVOFLONACIN-BASED SEQUENTIAL THERAPY VS CLARITHROMYCIN-BASED SEQUENTIAL THERAPY FOR ERADICATION OF H. PYLORI INFECTION
    Romano, M.
    Gravina, A. G.
    Federico, A.
    Miranda, A.
    Tiso, A.
    Schettino, P.
    Gaeta, L.
    Salerno, R.
    Cuomo, A.
    DIGESTIVE AND LIVER DISEASE, 2010, 42 : S112 - S113
  • [24] Pragmatic eradication of H-pylori
    Price, J
    Hamilton, W
    BRITISH JOURNAL OF GENERAL PRACTICE, 1997, 47 (423): : 660 - 660
  • [25] Nitroimidazoles for H-pylori eradication
    Archimandritis, A
    Tzivras, M
    Balatsos, V
    Delis, V
    Skandalis, N
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 1999, 13 (11) : 1563 - 1563
  • [26] H-pylori eradication by LAC
    Harris, A
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 1997, 11 (05) : 1001 - 1002
  • [27] Levofloxacin-based triple therapy in second-line treatment for H-pylori eradication:: Update.
    Nista, EC
    Candelli, M
    Santoro, M
    Cazzato, IA
    Finizio, R
    Fini, L
    Ojetti, V
    Zocco, MA
    Gabrielli, M
    Santarelli, L
    D'antona, G
    Cammarota, G
    Gasbarrini, GB
    Gasbarrini, A
    GASTROENTEROLOGY, 2005, 128 (04) : A63 - A63
  • [28] Second-line treatment for H-pylori eradication:: A new levofloxacin based strategy
    Nista, EC
    Candelli, M
    Di Caro, S
    Cremonini, F
    Cazzato, LA
    Zocco, MA
    Santarelli, L
    Gabrielli, M
    Gasbarrini, G
    Gasbarrini, A
    GUT, 2002, 51 : A100 - A100
  • [29] Sequential Levofloxacin modified therapy is superior to quadruple therapy but equivalent to standard Levofloxacin based second line treatment in patients with H-pylori infection
    Franceschi, F.
    Finizio, R.
    Campanale, M.
    Barbaro, F.
    Gigante, G.
    Cesario, V.
    Tortora, A.
    Calcinaro, S.
    Marsiliani, D.
    Carroccia, A.
    Silveri, N. Gentiloni
    Curro, D.
    Cammarota, G.
    Gasbarrini, G.
    Gasbarrini, A.
    HELICOBACTER, 2010, 15 (04) : 314 - 315
  • [30] Omeprazole (O) and clarithromycin (C) in H-pylori (HP) eradication: A meta-analysis.
    Chiba, N
    Wilkinson, J
    Hunt, RH
    GASTROENTEROLOGY, 1996, 110 (04) : A80 - A80
12345